Suppr超能文献

尽管存在快速进展的复发性肝细胞癌伴门静脉癌栓,但经动脉导管灌注仍实现完全病理缓解:一例报告

Complete pathological response to transcatheter arterial infusion despite a rapidly progressing recurrent hepatocellular carcinoma with portal vein tumor thrombus: A case report.

作者信息

Taguchi Masanobu, Sakuma Yasunaru, Sasanuma Hideki, Sata Naohiro, Lefor Alan Kawarai, Sasaki Takahiro, Tanaka Akira, Yasuda Yoshikazu

机构信息

Department of Surgery, Jichi Medical University, Japan.

Department of Surgery, Jichi Medical University, Japan.

出版信息

Int J Surg Case Rep. 2015;10:20-4. doi: 10.1016/j.ijscr.2015.03.015. Epub 2015 Mar 11.

Abstract

INTRODUCTION

We report a patient with a rapidly progressing recurrence of hepatocellular carcinoma (HCC) with a portal vein tumor thrombus after radiofrequency ablation of the original lesion, then treated with transcatheter arterial infusion. Radical hepatic resection demonstrated a complete pathological response.

PRESENTATION OF CASE

A 60-year old male with alcoholic cirrhosis and gastric varices was diagnosed with HCC measuring 12mm in segment 8. He underwent laparoscopic radiofrequency ablation, but recurred three months later. The lesion progressed rapidly and the right portal vein was occluded. He then underwent transcatheter arterial infusion with miriplatin and iodized oil, which was effective in reducing the size of the main lesion and portal vein tumor thrombus. Right anterior sectionectomy was then performed. Pathologically, there were no viable HCC cells in either the main lesion or the portal vein thrombus. He is alive two years and nine months after surgery without recurrence.

DISCUSSION

A rapidly progressing HCC recurrence with portal vein tumor thrombus is usually associated with a poor prognosis. No effective treatments have been reported in this situation except hepatic resection. In this patient the tumor was effectively reduced after three courses of transarterial miriplatin and subsequent radical hepatic resection. This is the first report to achieve a complete pathological response for such an aggressive recurrence after initial radiofrequency ablation.

CONCLUSION

This strategy may result in long-term survival of patients with rapidly progressing recurrent HCC with portal vein thrombus, and further study is warranted.

摘要

引言

我们报告了一例肝细胞癌(HCC)患者,在对原发病灶进行射频消融后,门静脉肿瘤血栓迅速进展复发,随后接受了经动脉灌注治疗。根治性肝切除显示出完全的病理反应。

病例介绍

一名60岁男性,患有酒精性肝硬化和胃静脉曲张,被诊断为肝段8处有一个12毫米的HCC。他接受了腹腔镜射频消融,但三个月后复发。病变迅速进展,右门静脉被阻塞。然后他接受了米铂和碘化油的经动脉灌注,这对缩小主要病变和门静脉肿瘤血栓的大小有效。随后进行了右前叶切除术。病理检查显示,主要病变或门静脉血栓中均无存活的HCC细胞。他在手术后两年零九个月存活,无复发。

讨论

伴有门静脉肿瘤血栓的HCC快速进展复发通常预后较差。除肝切除外,这种情况下尚无有效的治疗方法报道。在该患者中,经过三个疗程的经动脉米铂治疗及随后的根治性肝切除后,肿瘤得到有效缩小。这是首例对初次射频消融后如此侵袭性复发实现完全病理反应的报告。

结论

该策略可能使伴有门静脉血栓的HCC快速进展复发患者获得长期生存,值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ed/4429844/31d89aafbf06/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验